| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.7 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |